CD40 and B-cell neoplasm: CD40 is expressed on several types of B-cell neoplasms, including non-Hodgkin lymphoma (NHL), multiple myeloma, and chronic lymphocytic leukemia, making it an attractive potential tumor target for antibody-based cancer therapy [6].